Biomedical

Fox Chase Chemical Diversity Center, Inc. (FCCDC)
Jay Wrobel

FCCDC is an early-stage translational biomedical research company with core competencies in medicinal chemistry and drug discovery, seeking to be the partner of choice with academic and biotechnology companies in the small-molecule probe and therapy arenas.

http://www.fc-cdci.com/